Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Dawn of a New Era in Drug Discovery? Drug Screening and the Increasing Biological Complexity of Testing Models.

Chemical research in toxicology - 17 Jan 2022

Lin Wen-Jen

Abstract excerpt

Whole-organism phenotype screening and complex in vitro model technology increase the likelihood in identifying successful lead compounds and lower drug attrition rates at later and more expensive stages of the drug discovery process.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Discovery
Share to Drug Evaluation, Preclinical
Share to High-Throughput Screening Assays

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmaceutical Preparations

Share to Phenotype

Share to Zebrafish

Source

Open in PubMed Open full text

Identifiers

PMID: 34918914
DOI: 10.1021/acs.chemrestox.1c00331
PMCID: PMC9532213

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Dawn of a New Era in Drug Discovery? Drug Screening and the Increasing Biological Complexity of Testing Models.PMID 34918914Read ↗

Introduction to biological complexity as a missing link in drug discovery.Semantic proximity Read ↗

Complex phenotypic assays in high-throughput screening.Semantic proximity Read ↗

How Phenotypic Screening Influenced Drug Discovery: Lessons from Five Years of Practice.Semantic proximity Read ↗

Drug repurposing through nonhypothesis driven phenotypic screeningSemantic proximity Read ↗

Phenotypic screens as a renewed approach for drug discovery.Semantic proximity Read ↗

Phenotypic screens, chemical genomics, and antimalarial lead discovery.Semantic proximity Read ↗

Revitalizing antibiotic discovery and development through in vitro modelling of in-patient conditionsSemantic proximity Read ↗

The future of phenotypic drug discovery.Semantic proximity Read ↗

Innovation in academic chemical screening: filling the gaps in chemical biology.Semantic proximity Read ↗

The why and how of phenotypic small-molecule screens.Semantic proximity Read ↗

Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal modelsSemantic proximity Read ↗

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Phenotypic Drug Discovery.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.